€12.70
0.79% day before yesterday
Xetra, Nov 01, 05:36 pm CET
ISIN
DE0007042301
Symbol
RHK
Index

Rhön Klinikum Target price 2024 - Analyst rating & recommendation

Rhön Klinikum Classifications & Recommendation:

Hold
100%

Rhön Klinikum Price Target

Target Price €12.00
Price €12.70
Deviation
Number of Estimates 1
1 Analyst has issued a Rhön Klinikum price target 2025. The average Rhön Klinikum target price is €12.00. This is lower than the current stock price.
A rating was issued by 1 analysts: 0 Analysts recommend Rhön Klinikum to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Rhön Klinikum stock has an average upside potential 2025 of . Most analysts recommend the Rhön Klinikum stock at Hold.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Billion € 1.67 1.55
2.49% 7.50%
EBITDA Margin 2.73% 7.11%
49.53% 160.20%
Net Margin 2.32% 2.25%
48.92% 3.08%

1 Analyst has issued a sales forecast Rhön Klinikum 2024 . The average Rhön Klinikum sales estimate is

€1.5b
Unlock
. This is
3.26% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€1.5b 3.26%
Unlock
, the lowest is
€1.5b 3.26%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €1.7b 2.49%
2024
€1.5b 7.50%
Unlock
2025
€1.6b 5.17%
Unlock
2026
€1.7b 5.10%
Unlock
2027
€1.8b 5.13%
Unlock

1 Analyst has issued an EBITDA forecast Rhön Klinikum 2024 . The average Rhön Klinikum EBITDA estimate is

€110m
Unlock
. This is
14.19% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€110m 14.19%
Unlock
, the lowest is
€110m 14.19%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €45.7m 48.27%
2024
€110m 140.70%
Unlock
2025
€118m 7.27%
Unlock
2026
€127m 7.63%
Unlock
2027
€137m 7.95%
Unlock

EBITDA Margin

2023 2.73% 49.53%
2024
7.11% 160.20%
Unlock
2025
7.25% 1.97%
Unlock
2026
7.43% 2.48%
Unlock
2027
7.63% 2.69%
Unlock

1 Analyst has issued a net profit forecast Rhön Klinikum 2024 . The average Rhön Klinikum net profit estimate is

€34.8m
Unlock
. This is
25.71% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€34.8m 25.71%
Unlock
, the lowest is
€34.8m 25.71%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €38.8m 52.63%
2024
€34.8m 10.34%
Unlock
2025
€40.8m 17.29%
Unlock
2026
€47.5m 16.41%
Unlock
2027
€55.1m 15.95%
Unlock

Net Margin

2023 2.32% 48.92%
2024
2.25% 3.08%
Unlock
2025
2.51% 11.56%
Unlock
2026
2.78% 10.76%
Unlock
2027
3.07% 10.43%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share 0.58 0.52
52.63% 10.34%
P/E 24.42
EV/Sales 0.44

1 Analysts have issued a Rhön Klinikum forecast for earnings per share. The average Rhön Klinikum <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

€0.52
Unlock
. This is
25.71% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
€0.52 25.71%
Unlock
, the lowest is
€0.52 25.71%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €0.58 52.63%
2024
€0.52 10.34%
Unlock
2025
€0.61 17.31%
Unlock
2026
€0.71 16.39%
Unlock
2027
€0.82 15.49%
Unlock

P/E ratio

Current 18.27 38.13%
2024
24.42 33.66%
Unlock
2025
20.82 14.74%
Unlock
2026
17.89 14.07%
Unlock
2027
15.43 13.75%
Unlock

Based on analysts' sales estimates for 2024, the Rhön Klinikum stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.45 23.73%
2024
0.44 3.16%
Unlock
2025
0.41 4.93%
Unlock
2026
0.39 4.85%
Unlock
2027
0.38 4.87%
Unlock

P/S ratio

Current 0.57 9.77%
2024
0.55 3.17%
Unlock
2025
0.52 4.91%
Unlock
2026
0.50 4.86%
Unlock
2027
0.47 4.87%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today